Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients’ diagnosis and prognosis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0313042 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Marwa A Ali und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Medical Biochemistry and Molecular Biology, Fayoum University, Fayoum, Egypt. Hauptthemen laut MEDLINE: COVID-19, Interleukin-6, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The SARS-CoV-2 virus’s frequent mutations have made disease control with vaccines and antiviral drugs difficult; as a result, there is a need for more effective coronavirus drugs. Therefore, detecting the expression of various diagnostic biomarkers, including ncRNA in SARS-CoV2, implies new therapeutic strategies for the disease.
Aim
Our study aimed to measure NEAT-1, miR-374b-5p, and IL6 in the serum of COVID-19 patients, demonstrating the correlation between target genes to explore the possible relationship between them. Also, the association between target genes and patients’ clinical findings and radiological severity indices will be explored. Patients and methods The current study included 48 COVID-19-infected individuals and 40 controls. Quantitative real-time PCR (qPCR) was performed to detect lncRNA NEAT-1 and miRNA374b-5p fold change (FC) in the participants’ sera. Enzyme-Linked Immune Sorbent Assay (ELISA) is used to detect IL6 .
Results
Our results showed statistical significance with lower levels of ( NEAT-1 ) [ median (range) = 0.08 (0.001-0.602)], and ( miR374b-5p ) [ median (range) = 0.14 (.01-7.16)] while higher IL-6 levels [ median (range) = 41.3 (7.2-654) pg/ml] when compared to controls with p-value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Medical Biochemistry and Molecular Biology, Fayoum University, Fayoum, Egypt.
- Department of Biomedical Sciences, College of Medicine, King Faisal University, Alhasa, Saudi Arabia.
- Faculty of Medicine, Department of Medical Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt.
- Faculty of Medicine, Department of Internal Medicine, Fayoum University, Fayoum, Egypt.
- Faculty of Medicine, Department of Medical Microbiology and Immunology, Fayoum University, Fayoum, Egypt.
- Faculty of Medicine, Department of Radio-Diagnosis, Fayoum University, Fayoum, Egypt.
ORCID-Profile: Marwa A Ali
Zitieren
APA
Ali, M. A., Shaker, O. G., Ezzat, E. M., Ali, E. S. G., Aboelor, M. I., Ahmed, M. I., Hassan, E. A., Ali, D. Y., Ahmed, H. M., Khalefa, A. A., Hussein, R. A., Elkhateeb, A. F., & Mohamed, E. A. (2024). Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients’ diagnosis and prognosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0313042
Vancouver
Ali MA, Shaker OG, Ezzat EM, Ali ESG, Aboelor MI, Ahmed MI, et al. Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients’ diagnosis and prognosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0313042
BibTeX
@article{Ali2024,
author = {Ali, Marwa A and Shaker, Olfat G and Ezzat, Eman M and Ali, El Shaimaa Gomaa and Aboelor, Mahmoud I and Ahmed, Mona I and Hassan, Essam A and Ali, Doaa Y and Ahmed, Heba Mostafa and Khalefa, Abeer A and Hussein, Rasha A and Elkhateeb, Ahmed Fathy and Mohamed, Esam Ali},
title = {Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients’ diagnosis and prognosis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0313042}
}
EUVIMED